Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$0.49
C$0.52
C$0.45
C$0.69
C$8.93M1.6915,150 shsN/A
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$29.19
+0.3%
$27.89
$13.70
$30.50
$58.27B0.972.54 million shs1.83 million shs
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$0.07
C$0.08
C$0.06
C$0.12
C$26.98M0.88324,385 shs120,312 shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$716.91
+0.5%
$658.89
$442.65
$747.90
$1.81T1.2814.57 million shs8.60 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00%-2.02%-8.49%-13.39%-8.49%
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
0.00%-3.95%+6.81%+42.84%+71.40%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00%-7.14%-13.33%-27.78%-13.33%
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.00%-2.28%+4.21%+42.04%+40.58%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
2.8483 of 5 stars
0.03.00.80.01.90.03.8
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
3.9647 of 5 stars
2.54.01.70.03.43.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00
N/AN/AN/A
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
2.86
Moderate BuyN/AN/A
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.00
N/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
2.93
Moderate Buy$719.290.33% Upside

Current Analyst Ratings Breakdown

Latest CTX, META, LABS, and DB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/3/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Hold
7/2/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$635.00 ➝ $740.00
6/27/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$650.00 ➝ $808.00
6/26/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$683.00 ➝ $812.00
6/24/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$690.00 ➝ $803.00
6/18/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$676.00 ➝ $807.00
6/17/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$664.00
6/16/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$665.00 ➝ $775.00
6/12/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/12/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$690.00 ➝ $765.00
6/10/2025
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$16.62M0.54C$0.40 per share1.20C$0.83 per share0.58
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$71.84B0.81$3.01 per share9.70$44.47 per share0.66
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
C$39.42M0.68C$0.05 per share1.30C$0.11 per share0.59
Meta Platforms, Inc. stock logo
META
Meta Platforms
$164.50B10.96$30.64 per share23.40$72.08 per share9.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
-C$2.61M-C$0.15N/AN/A-15.73%-15.60%-8.26%N/A
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$4.70B$1.6817.389.390.375.76%4.61%0.27%7/23/2025 (Estimated)
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
-C$12.05M-C$0.03N/AN/A-30.56%-24.41%-7.17%N/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$62.36B$25.6427.9623.731.7639.11%38.69%25.56%7/30/2025 (Estimated)

Latest CTX, META, LABS, and DB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
$5.75N/AN/AN/A$44.55 billionN/A
7/23/2025Q2 2025
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$0.83N/AN/AN/A$7.80 billionN/A
4/30/2025Q1 2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
$5.33$6.43+$1.10$6.43$41.45 billion$42.31 billion
4/29/2025Q1 2025 Prepared Remarks
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$0.85$1.04+$0.19$1.04$7.95 billion$8.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/A
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
N/AN/AN/AN/A4 Years
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
N/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$2.100.29%N/A8.19%1 Years

Latest CTX, META, LABS, and DB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/29/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
quarterly$0.52500.33%6/16/20256/16/20256/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
5.77
2.70
2.29
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
1.39
0.79
0.79
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
1.45
3.21
3.10
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.16
2.66
2.66

Institutional Ownership

CompanyInstitutional Ownership
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/A
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
27.90%
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
0.71%
Meta Platforms, Inc. stock logo
META
Meta Platforms
79.91%
CompanyEmployeesShares OutstandingFree FloatOptionable
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
6218.41 millionN/ANot Optionable
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
89,7531.99 billionN/AOptionable
MediPharm Labs Corp. stock logo
LABS
MediPharm Labs
130415.00 millionN/ANot Optionable
Meta Platforms, Inc. stock logo
META
Meta Platforms
74,0672.51 billion2.17 billionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Crescita Therapeutics stock logo

Crescita Therapeutics TSE:CTX

C$0.48 0.00 (0.00%)
As of 07/3/2025

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Deutsche Bank Aktiengesellschaft stock logo

Deutsche Bank Aktiengesellschaft NYSE:DB

$29.19 +0.10 (+0.34%)
Closing price 07/3/2025 03:41 PM Eastern
Extended Trading
$29.19 0.00 (0.00%)
As of 07/3/2025 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Deutsche Bank Aktiengesellschaft, a stock corporation, provides corporate and investment banking, and asset management products and services to private individuals, corporate entities, and institutional clients in Germany, the United Kingdom, rest of Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through Corporate Bank, Investment Bank, Private Bank, and Asset Management segments. The Corporate Bank segment offers cash management, trade finance and lending, trust and agency, and securities services, as well as risk management solutions. The Investment Bank segment provides debt origination, merger and acquisitions, foreign exchange, and equity advisory and origination platform services. The Private Bank segment offers payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management, other financial, and postal and parcel services; and supports in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The Asset Management segment offers investment solutions, such as alternative investments, which include real estate, infrastructure, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

MediPharm Labs stock logo

MediPharm Labs TSE:LABS

C$0.06 0.00 (0.00%)
As of 07/4/2025 01:33 PM Eastern

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4. Its geographical segments are Canada and Australia.

Meta Platforms stock logo

Meta Platforms NASDAQ:META

$716.90 +3.34 (+0.47%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$717.58 +0.67 (+0.09%)
As of 07/3/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California